Cargando…

Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients

INTRODUCTION: The incidence of invasive pulmonary aspergillosis (IPA) in intensive care unit (ICU) patients is increasing, and early diagnosis of the disease and treatment with antifungal drugs is critical for patient survival. Serum biomarker tests for IPA typically give false-negative results in n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eigl, Susanne, Prattes, Juergen, Lackner, Michaela, Willinger, Birgit, Spiess, Birgit, Reinwald, Mark, Selitsch, Brigitte, Meilinger, Michael, Neumeister, Peter, Reischies, Frederike, Wölfler, Albert, Raggam, Reinhard B, Flick, Holger, Eschertzhuber, Stephan, Krause, Robert, Buchheidt, Dieter, Thornton, Christopher R, Lass-Flörl, Cornelia, Hoenigl, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421996/ https://www.ncbi.nlm.nih.gov/pubmed/25927915 http://dx.doi.org/10.1186/s13054-015-0905-x

Ejemplares similares

1462 Bronchoalveolar Lavage Lateral-Flow Device Test for Diagnosing Invasive Pulmonary Aspergillosis in ICU patients: a multicenter study
por: Hoenigl, Martin, et al.
Publicado: (2014)

2567. Diagnosis of Invasive Aspergillosis in Hematological Malignancy Patients Receiving Mold-Active Antifungals: Performance of Interleukin-6 and -8, Asp LFD, and Aspergillus PCR in Same-day Blood and Bronchoalveolar Lavage Fluid Samples
por: Hoenigl, Martin, et al.
Publicado: (2018)

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
por: Jenks, Jeffrey D, et al.
Publicado: (2018)

A Retrospective Assessment of Four Antigen Assays for the Detection of Invasive Candidiasis Among High-Risk Hospitalized Patients
por: Hartl, Barbara, et al.
Publicado: (2018)

Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection
por: Rawlings, Stephen A., et al.
Publicado: (2019)

Incidence of Cyp51 A Key Mutations in Aspergillus fumigatus—A Study on Primary Clinical Samples of Immunocompromised Patients in the Period of 1995–2013
por: Spiess, Birgit, et al.
Publicado: (2014)

COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges
por: Prattes, Juergen, et al.
Publicado: (2021)

Utility of Serum 1,3-β-d-Glucan Testing for Diagnosis and Prognostication in COVID-19-Associated Pulmonary Aspergillosis
por: Egger, Matthias, et al.
Publicado: (2022)

Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?
por: Prattes, Juergen, et al.
Publicado: (2016)

Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis
por: Hoenigl, Martin, et al.
Publicado: (2023)

Diagnostic Performance of an Aspergillus-Specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis
por: Reinwald, Mark, et al.
Publicado: (2013)

Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis
por: Tavakoli, Mahin, et al.
Publicado: (2020)

The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update
por: Jenks, Jeffrey D., et al.
Publicado: (2020)

Characteristics of Hospital-Acquired and Community-Onset Blood Stream Infections, South-East Austria
por: Hoenigl, Martin, et al.
Publicado: (2014)

Aspergillus fumigatus and Its Allergenic Ribotoxin Asp f I: Old Enemies but New Opportunities for Urine-Based Detection of Invasive Pulmonary Aspergillosis Using Lateral-Flow Technology
por: Davies, Genna, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report
por: Prattes, Juergen, et al.
Publicado: (2020)

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
por: Arastehfar, Amir, et al.
Publicado: (2020)

Clinical Usefulness of Susceptibility Breakpoints for Yeasts in the Treatment of Candidemia: A Noninterventional Study
por: Lass-Flörl, Cornelia, et al.
Publicado: (2020)

Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two‐centre mixed cohort study
por: Hoenigl, Martin, et al.
Publicado: (2021)

Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease - review of the literature
por: Mayr, A, et al.
Publicado: (2011)

Hypoxia Decreases Diagnostic Biomarkers for Aspergillosis In Vitro
por: Maurer, Elisabeth, et al.
Publicado: (2019)

COVID-19-Associated Pulmonary Aspergillosis Isolates Are Genomically Diverse but Similar to Each Other in Their Responses to Infection-Relevant Stresses
por: Mead, Matthew E., et al.
Publicado: (2023)

Diagnosing COVID-19-associated pulmonary aspergillosis
por: Verweij, Paul E, et al.
Publicado: (2020)

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
por: Hoenigl, Martin, et al.
Publicado: (2021)

COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility
por: Lackner, Nina, et al.
Publicado: (2022)

Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing
por: Spettel, Kathrin, et al.
Publicado: (2019)

Clinical evaluation of an in-house panfungal real-time PCR assay for the detection of fungal pathogens
por: Camp, Iris, et al.
Publicado: (2020)

Identification of Filamentous Fungi by MALDI-TOF Mass Spectrometry: Evaluation of Three Different Sample Preparation Methods and Validation of an In-House Species Cutoff
por: Honsig, Claudia, et al.
Publicado: (2022)

Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection
por: Jenks, Jeffrey D., et al.
Publicado: (2019)

Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
por: Salzer, Helmut J. F., et al.
Publicado: (2018)

Parallel and cross-resistances of clinical yeast isolates determined by susceptibility pattern analysis
por: Schmalreck, Arno F., et al.
Publicado: (2016)

Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study
por: Autier, Brice, et al.
Publicado: (2022)

Longitudinal Evaluation of Plasma Cytokine Levels in Patients with Invasive Candidiasis
por: Wunsch, Stefanie, et al.
Publicado: (2021)

Treatment of Aspergillosis
por: Jenks, Jeffrey D., et al.
Publicado: (2018)

Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
por: Hatzl, Stefan, et al.
Publicado: (2021)

Aspergillus fumigatus and aspergillosis: From basics to clinics
por: Arastehfar, A., et al.
Publicado: (2021)

Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience
por: Lass-Flörl, Cornelia, et al.
Publicado: (2017)

Microbiological and Molecular Diagnosis of Mucormycosis: From Old to New
por: Lackner, Nina, et al.
Publicado: (2021)

Editorial: Diagnostic Approaches for Aspergillus Infections
por: Salzer, Helmut J. F., et al.
Publicado: (2019)

2268. Clinical Implications of Azole-Resistant vs. Azole-Susceptible Invasive Aspergillosis in Hematological Malignancy (CLARITY): A Multicenter Study
por: Seidel, Danila, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ksgkj1agn0d4vr9cl1reu71kb7